Business Context and Reporting Period
This Form 8-K was filed by Reinvent Technology Partners Z, not Hippo Holdings Inc., on November 30, 2020, regarding events occurring November 23, 2020. The filing reports the completion of the registrant’s initial public offering and related private warrant placement. The filing text does not mention Hippo Holdings Inc. or a business combination.
Key Financial Metrics and Capitalization
| Item | Amount or Terms |
|---|---|
| IPO units issued | 23,000,000 units, including 3,000,000 units from the underwriter’s over-allotment option |
| IPO price | $10.00 per unit |
| Gross IPO proceeds | $230.0 million |
| Private placement warrants | 4,400,000 warrants sold to Reinvent Sponsor Z LLC at $1.50 each |
| Gross private placement proceeds | $6.6 million |
| Trust account deposit | $230.0 million placed in a U.S.-based trust account at JPMorgan Chase Bank, N.A. |
| Warrant exercise price | $11.50 per ordinary share, subject to adjustment |
The filing does not provide revenue, operating profit, net income, cash flow, margins, debt, or liquidity metrics beyond the IPO and trust-account proceeds. An audited balance sheet as of November 23, 2020 was filed as Exhibit 99.1, but its detailed figures are not included in the provided text.
Material Changes Versus Prior Period
The filing describes the consummation of the IPO and private warrant placement. No comparable-period financial information or prior-period operating results are provided.
Outlook, Risks, Contingencies, and Unusual Items
- The proceeds were placed in a trust account maintained by Continental Stock Transfer & Trust Company as trustee.
- The filing does not provide acquisition guidance, target-company information, management outlook, or timing for a business combination.
- The securities include redeemable warrants and private placement warrants, which may create future dilution if exercised.
- The filing does not describe material contingencies or unusual operating items.
Investor Verification Items
- Verify that the filing pertains to Reinvent Technology Partners Z rather than Hippo Holdings Inc.
- Review Exhibit 99.1 for the audited balance sheet and any liabilities, offering costs, or other balance-sheet details.
- Confirm the terms and potential dilution associated with the public and private warrants.
- Determine whether a subsequent filing identifies a target business or business-combination agreement.